Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:32:36 GMT 2025
by
admin
on
Mon Mar 31 20:32:36 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
XRO4566Q4R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000007668
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
AVONIX (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
WHO-VATC |
QL03AB07
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
95195
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
69392
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
111598
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
63391
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
WHO-ATC |
L03AB07
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
115498
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
NDF-RT |
N0000007956
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
REBIF (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
NDF-RT |
N0000007668
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
62791
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
NDF-RT |
N0000175747
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
62891
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
53290
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
||
|
NDF-RT |
N0000007668
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8339
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
FF-5
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
m6305
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
145258-61-3
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
XRO4566Q4R
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
SUB12440MIG
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
1342412
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
ALTERNATIVE | |||
|
CHEMBL1201562
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
C086937
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
DB00060
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
8135
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
1342401
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
220581-49-7
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
ALTERNATIVE | |||
|
5139
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
75917
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | RxNorm | ||
|
C1823
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
INTERFERON BETA 1A
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
XRO4566Q4R
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY | |||
|
100000089299
Created by
admin on Mon Mar 31 20:32:36 GMT 2025 , Edited by admin on Mon Mar 31 20:32:36 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_31 | 1_141 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_80 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:APPROXIMATE | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|